JD Health International Inc. (HKG:6618)

JD Health International Financials Overview

Financials in millions CNY. Fiscal year is January - December.

Revenue & Profits

Chart

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Revenue Revenue Growth	73,441	73,441	58,160	53,530	46,736	30,682
Revenue Growth	12.80%	26.27%	8.65%	14.54%	52.32%	58.30%
Gross Profit Gross Profit Growth	18,199	18,199	13,309	11,865	9,892	7,197
Operating Income Operating Income Growth	3,798	3,798	1,163	630.85	-145.12	-1,404
Net Income Net Income Growth	5,375	5,375	4,162	2,142	380.11	-1,074
Earnings Per Share EPS Growth	1.68	1.68	1.32	0.68	0.12	-0.35
EPS Growth	13.47%	27.27%	94.12%	466.67%	-	-

Cash & Debt

Chart

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Investments Cash & Investments Growth	48,151	48,151	51,236	41,221	47,672	41,990
Total Debt Total Debt Growth	636.02	636.02	258.39	214.75	199.41	201.27
Net Cash (Debt) Net Cash Growth	47,514	47,514	50,977	41,007	47,473	41,789
Net Cash Growth	-2.79%	-6.79%	24.32%	-13.62%	13.60%	3.92%
Net Cash Per Share Net Cash Per Share Growth	14.87	14.87	16.13	12.96	15.10	13.50

Cash Flow & CapEx

Chart

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Operating Cash Flow Operating Cash Flow Growth	10,174	10,174	4,332	4,605	5,905	3,431
Capital Expenditures CapEx Growth	-151.01	-151.01	-46.36	-61.18	-40.16	-502.21
Free Cash Flow Free Cash Flow Growth	10,023	10,023	4,286	4,544	5,865	2,929
Free Cash Flow Growth	20.97%	133.85%	-5.67%	-22.53%	100.27%	-20.50%

Margins

Chart

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Gross Margin	24.78%	24.78%	22.88%	22.17%	21.16%	23.46%
Operating Margin	5.17%	5.17%	2.00%	1.18%	-0.31%	-4.58%
Pretax Margin	8.21%	8.21%	8.25%	5.03%	1.49%	-2.94%
Profit Margin	7.32%	7.32%	7.16%	4.00%	0.81%	-3.50%
FCF Margin	13.65%	13.65%	7.37%	8.49%	12.55%	9.54%

Valuation

Chart

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug 2, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
PE Ratio	21.07	29.78	20.29	52.84	528.00	-
Forward PE	15.67	24.37	17.60	26.41	67.40	112.32
P/FCF Ratio	11.27	15.97	19.71	24.91	34.22	54.61
PS Ratio	1.54	2.18	1.45	2.11	4.29	5.21

Data Source: S&P Global Market Intelligence Last updated: Dec 31, 2025

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Jul 31, 2026

Data Sources Report a data error